(Sharecast News) - Pfizer and BioNTech have reported positive results from their trial of a Covid-19 vaccine for children aged 5-12.
The companies said a phase 2/3 trial on 20 September the vaccine showed a favourable safety profile and produced neutralising antibody responses using a two-dose regime.

The results compared...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE